Near-infrared fluorescence molecular imaging of amyloid beta species and monitoring therapy in animal models of Alzheimer’s disease
Near-infrared fluorescence (NIRF) molecular imaging has been widely applied to monitoring therapy of cancer and other diseases in preclinical studies; however, this technology has not been applied successfully to monitoring therapy for Alzheimer’s disease (AD). Although several NIRF probes for detec...
Main Authors: | Zhang, Xueli, Tian, Yanli, Zhang, Can, Tian, Xiaoyu, Ross, Alana W., Moir, Robert D., Sun, Hongbin, Tanzi, Rudolph E., Moore, Anna V., Ran, Chongzhao |
---|---|
Other Authors: | Harvard University--MIT Division of Health Sciences and Technology |
Format: | Article |
Language: | en_US |
Published: |
National Academy of Sciences (U.S.)
2016
|
Online Access: | http://hdl.handle.net/1721.1/101113 |
Similar Items
-
Non-Conjugated Small Molecule FRET for Differentiating Monomers from Higher Molecular Weight Amyloid Beta Species
by: Ran, Chongzhao, et al.
Published: (2011) -
Near-infrared fluorescent probes for imaging of amyloid plaques in Alzheimer׳s disease
by: Hongjuan Tong, et al.
Published: (2015-01-01) -
The consequences of mitochondrial amyloid beta-peptide in Alzheimer's disease.
by: Muirhead, K, et al.
Published: (2010) -
Amyloid beta and Alzheimer’s Disease: The role of neprilysin-2 in amyloid-beta clearance
by: Robert eMarr, et al.
Published: (2014-08-01) -
Amyloid Beta in Aging and Alzheimer’s Disease
by: Ujala Sehar, et al.
Published: (2022-10-01)